- In December 2023, McKesson Corporation launched its Maternal and Fetal Health Intelligence Platform, leveraging extensive clinical data and analytics. The platform provides real-time insights on maternal and fetal health trends, enabling healthcare providers to identify high-risk pregnancies. By optimizing care delivery, it helps improve outcomes for both mothers and infants, offering a valuable tool for better management and decision-making in perinatal care
- In November 2023, PeriGen and Invu Health formed a strategic partnership to enhance fetal growth monitoring. PeriGen’s clinical decision support tools were integrated with Invu Health’s wearable biopatch, offering continuous monitoring of maternal and fetal vital signs. This collaboration aims to improve pregnancy management by providing healthcare providers with real-time, holistic insights, facilitating early detection of complications, and enhancing overall maternal and fetal health
- In October 2023, GE HealthCare Technologies acquired Caption Health, a leader in AI-driven ultrasound image analysis. The acquisition grants GE access to Caption Health’s software, which automates the analysis of fetal ultrasound images, detecting abnormalities early. This integration strengthens GE’s ultrasound product line and promotes the adoption of AI-powered solutions in perinatal care, potentially improving maternal and fetal health outcomes through advanced diagnostic tools
- In August 2023, PeriGen Inc. launched the LaborWatch platform, a breakthrough AI-powered tool for maternal-fetal assessments. Following successful implementation in a major US health system, LaborWatch uses artificial intelligence to monitor labor progression and escalates persistent issues with automated SMS notifications. This innovative technology enhances the ability of healthcare providers to track and address critical concerns in real time, improving patient outcomes in labor and delivery
- In December 2022, Memora Health Inc. partnered with PeriGen Inc. to offer comprehensive virtual care solutions for women’s health. This collaboration bridges the gap between labor, delivery, and postpartum care, ensuring continuous support for expectant mothers. By integrating AI-driven perinatal tools, the partnership aims to provide seamless, personalized healthcare, enhancing the overall experience and outcomes for women during and after pregnancy
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Product and Services), Deployment Model (On–Premise, Cloud–Based and Web-Based), Application (Fetal Monitoring, Workflow Management, Patient Documentation, EMR Workflow Management and Others), End User (Hospitals, Speciality/ Maternity Clinics and Others) – Industry Trends and Forecast to 2032
.
The Global Clinical Perinatal Software Market size was valued at USD 299.60 USD Million in 2024.
The Global Clinical Perinatal Software Market is projected to grow at a CAGR of 8.08% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
